Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease 论文
2020Nature Communications引用 561顶会
SARS-CoV-2 and COVID-19 ResearchComputational Drug Discovery MethodsViral gastroenteritis research and epidemiology
摘要
as main mechanism of inhibition. Our findings may provide critical information for the optimization and design of more potent inhibitors against the emerging SARS-CoV-2 virus.